JP6423701B2 - Cosmetics - Google Patents
Cosmetics Download PDFInfo
- Publication number
- JP6423701B2 JP6423701B2 JP2014246785A JP2014246785A JP6423701B2 JP 6423701 B2 JP6423701 B2 JP 6423701B2 JP 2014246785 A JP2014246785 A JP 2014246785A JP 2014246785 A JP2014246785 A JP 2014246785A JP 6423701 B2 JP6423701 B2 JP 6423701B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- component
- preferable
- skin
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002537 cosmetic Substances 0.000 title claims description 37
- 229940106189 ceramide Drugs 0.000 claims description 37
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- -1 glycerin monoalkyl ether Chemical class 0.000 claims description 31
- 239000002253 acid Substances 0.000 claims description 24
- 235000011187 glycerol Nutrition 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 12
- 150000001783 ceramides Chemical class 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 7
- 235000013922 glutamic acid Nutrition 0.000 claims description 7
- 239000004220 glutamic acid Substances 0.000 claims description 7
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 6
- 210000003491 skin Anatomy 0.000 description 38
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 23
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 23
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 23
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 23
- 239000000284 extract Substances 0.000 description 21
- 239000000203 mixture Substances 0.000 description 19
- 238000002425 crystallisation Methods 0.000 description 16
- 230000008025 crystallization Effects 0.000 description 16
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 239000000499 gel Substances 0.000 description 13
- 239000013078 crystal Substances 0.000 description 11
- 230000003993 interaction Effects 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229960002989 glutamic acid Drugs 0.000 description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 229960003646 lysine Drugs 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940049906 glutamate Drugs 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 239000002649 leather substitute Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000012916 structural analysis Methods 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229940099417 ceramide 2 Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- ULMXYNZCSJBKOQ-UHFFFAOYSA-N n-(3-hexadecoxy-3-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOC(O)CCN(CCO)C(=O)CCCCCCCCCCCCCCC ULMXYNZCSJBKOQ-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- SCWWKKUJPHRBRV-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;sodium Chemical compound [Na].NCCCC[C@H](N)C(O)=O SCWWKKUJPHRBRV-JEDNCBNOSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- OOWQBDFWEXAXPB-UHFFFAOYSA-N 1-O-palmitylglycerol Chemical compound CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- MACVUTCNLULHLQ-UHFFFAOYSA-N 2-[methyl(octadecanoyl)amino]ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)N(C)CCS(O)(=O)=O MACVUTCNLULHLQ-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- WAYLDHLWVYQNSQ-KEFDUYNTSA-N N-2-hydroxylignoceroylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC WAYLDHLWVYQNSQ-KEFDUYNTSA-N 0.000 description 1
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010039491 Ricin Proteins 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229940095137 ceramide 6 ii Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229930000756 phytoceramide Natural products 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000005068 transpiration Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000004736 wide-angle X-ray diffraction Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、化粧料に関する。 The present invention relates to a cosmetic.
α−ゲルは、水和型の結晶構造であり、ラメラ構造を有する。皮膚最外層の角層に存在する角層細胞間脂質も、その大半がこのα−ゲル構造をとっている。そして、皮膚に対して、外部からの物質の侵入、内部からの水分蒸散を抑制すると同時に、そのもの自身が水分を保持することで、皮膚の柔軟性やなめらかな外観を保つ機能を有している。皮膚中において、角層は、水分を結合水の形で約33質量%保持しており、角層細胞間脂質は、約13質量%の結合水を保持していることが知られている。
このように、α−ゲルは水分を保持することができるため、化粧料などへの適用が検討されている。
α-gel is a hydrated crystal structure and has a lamellar structure. Most of the stratum corneum intercellular lipids present in the outermost layer of the skin also have this α-gel structure. And it has the function of maintaining the softness and smooth appearance of the skin by suppressing the invasion of substances from the outside and the moisture transpiration from the inside as well as holding the moisture itself. . It is known that in the skin, the stratum corneum retains about 33% by mass of water in the form of bound water, and the stratum corneum intercellular lipid retains about 13% by weight of bound water.
Thus, since α-gel can retain moisture, application to cosmetics and the like has been studied.
例えば、特許文献1には、セラミド類、グリセリンモノ脂肪酸エステル、高級アルコール、アニオン界面活性剤等を含有する乳化組成物が、α−ゲル構造を形成することが記載され、特許文献2には、セラミド類、グリセリンモノ脂肪酸エステル、高級アルコール、アニオン界面活性剤、特定の極性油を含有する乳化組成物が、α−ゲル構造を形成することが記載されている。 For example, Patent Document 1 describes that an emulsified composition containing a ceramide, a glycerin monofatty acid ester, a higher alcohol, an anionic surfactant, and the like forms an α-gel structure. It is described that an emulsified composition containing a ceramide, a glycerin monofatty acid ester, a higher alcohol, an anionic surfactant, and a specific polar oil forms an α-gel structure.
しかしながら、特許文献1の乳化組成物は、肌に塗布した後に肌を触ると、きしみ感が感じられた。また、特許文献2では、α−ゲル構造をとる乳化物に特定の極性油を組合わることで、きしみ感を改善されるものの、化粧料を塗布していない場合の肌と比べて、よりなめらかな感触が得られような使用感の向上が得られず、また、塗布後の肌に油剤を塗布したようなてかりのある不自然な光沢感が見られた。
そのため、α−ゲル構造を形成し、塗布後の肌に、なめらかな感触が得られ、さらに、塗布後の肌に自然なつや感が得られる化粧料が望まれた。
本発明は、α−ゲルを形成する化粧料において、安定性に優れ、塗布後の肌を指で触るとなめらかな感触が得られ、また、肌に自然なつや感がみられる化粧料に関する。
However, when the emulsion composition of Patent Document 1 is applied to the skin and touched with the skin, a squeaky feeling was felt. Moreover, in patent document 2, although a squeak feeling is improved by combining a specific polar oil with the emulsion which has an alpha gel structure, compared with the skin when not applying cosmetics, it is smoother. It was not possible to improve the feeling of use such that a good feel was obtained, and there was an unnatural glossiness with a feeling like applying an oil to the skin after application.
Therefore, there has been a demand for a cosmetic that forms an α-gel structure, provides a smooth feel to the skin after application, and provides a natural gloss to the skin after application.
The present invention relates to a cosmetic that forms an α-gel and has excellent stability, a smooth feel can be obtained when the skin after application is touched with a finger, and the skin has a natural gloss.
本発明者らは、特定のグリセリンモノ脂肪酸エステル又はグリセリンモノアルキルエーテルと、高級アルコール、セラミド類、ジアシルグルタミン酸リシン塩、及び水を、特定の割合で組み合わせることで、皮膚に塗布した際に、α−ゲル構造をとり、安定性に優れ、塗布した後の肌がなめらか感触となり、見た目に自然なつや感が得られることを見出した。 The present inventors combined specific glycerin monofatty acid ester or glycerin monoalkyl ether with higher alcohol, ceramides, diacylglutamic acid lysine salt, and water at a specific ratio, and when applied to the skin, -It has been found that it has a gel structure, is excellent in stability, has a smooth feel after application, and has a natural gloss feeling.
本発明は、次の成分(A)、(B)、(C)、(D)及び(E):
(A)炭素数10〜24の直鎖脂肪酸を由来とするグリセリンモノ脂肪酸エステル又はグリセリンモノアルキルエーテル 0.01〜6質量%、
(B)炭素数8〜20の高級アルコール 0.05〜6質量%、
(C)セラミド類 0.01〜8質量%、
(D)ジアシルグルタミン酸リシン塩 0.01〜1.5質量%、
(E)水
を含有し、成分(D)の酸換算量に対する成分(A)、(B)及び(C)の合計含有量の質量割合[((A)+(B)+(C))/(D)]が、1〜220である化粧料に関する。
The present invention includes the following components (A), (B), (C), (D) and (E):
(A) 0.01 to 6% by mass of glycerin monofatty acid ester or glycerin monoalkyl ether derived from a linear fatty acid having 10 to 24 carbon atoms,
(B) 0.05 to 6% by mass of a higher alcohol having 8 to 20 carbon atoms,
(C) Ceramides 0.01-8% by mass,
(D) Diacyl glutamic acid lysine salt 0.01 to 1.5% by mass,
(E) Mass ratio of the total content of components (A), (B) and (C) with respect to the acid equivalent amount of component (D) [((A) + (B) + (C)) / (D)] is related with the cosmetics which are 1-220.
本発明の化粧料は、α−ゲル構造を形成し、セラミドの結晶化を抑制して安定に含有するとともに、塗布した後の肌をなめらかにすることができ、さらに、塗布後の肌につや感を得ることができる。 The cosmetic composition of the present invention forms an α-gel structure, suppresses crystallization of ceramide and stably contains it, and can smooth the skin after application, and further, gloss on the skin after application. A feeling can be obtained.
本発明で用いる成分(A)の炭素数10〜24の直鎖脂肪酸を由来とするグリセリンモノ脂肪酸エステル又はグリセリンモノアルキルエーテルとしては、例えば、グリセリンモノラウリン酸エステル、グリセリンモノミリスチン酸エステル、グリセリンモノパルミチン酸エステル、グリセリンモノステアリン酸エステル、グリセリンモノベヘン酸エステル、グリセリンモノオレイン酸エステル、モノセチルグリセリルエーテル、モノステアリルグリセリルエーテル等が挙げられる。
成分(A)のグリセリンモノ脂肪酸エステルを構成する脂肪酸の炭素数は、成分(B)及び(D)との相互作用により、セラミドの結晶化を抑制させる点から、12〜24が好ましく、14〜22がより好ましい。
また、成分(A)のグリセリンモノアルキルエーテルを構成する脂肪酸の炭素数は、成分(B)及び(D)との相互作用により、セラミドの結晶化を抑制させる点から、12〜24が好ましく、14〜22がより好ましく、16〜18がさらに好ましい。
Examples of the glycerol mono fatty acid ester or glycerol monoalkyl ether derived from the linear fatty acid having 10 to 24 carbon atoms of the component (A) used in the present invention include glycerol monolaurate, glycerol monomyristate, and glycerol monopalmitin. Examples include acid esters, glycerol monostearate, glycerol monobehenate, glycerol monooleate, monocetyl glyceryl ether, and monostearyl glyceryl ether.
The number of carbon atoms of the fatty acid constituting the glycerin monofatty acid ester of the component (A) is preferably 12 to 24 from the viewpoint of suppressing the crystallization of ceramide by interaction with the components (B) and (D). 22 is more preferable.
In addition, the number of carbon atoms of the fatty acid constituting the glycerin monoalkyl ether of component (A) is preferably 12 to 24 from the viewpoint of suppressing crystallization of ceramide by interaction with components (B) and (D). 14-22 are more preferable and 16-18 are still more preferable.
成分(A)は、1種又は2種以上を組合わせて用いることができ、セラミドの結晶化を抑制し、塗布後の肌のつや感を向上させる点から、含有量は、全組成中に0.01〜6質量%であり、0.05〜3.5質量%が好ましく、0.1〜1.5質量%がより好ましい。 Component (A) can be used singly or in combination of two or more, and suppresses the crystallization of ceramide and improves the glossiness of the skin after application, so the content is in the total composition It is 0.01-6 mass%, 0.05-3.5 mass% is preferable, and 0.1-1.5 mass% is more preferable.
本発明で用いる成分(B)は、炭素数8〜20の高級アルコールであり、例えば、ラウリルアルコール、ミリスチルアルコール、セタノール、ステアリルアルコール、オレイルアルコール等が挙げられる。
高級アルコールの炭素数は、成分(A)及び(D)との相互作用により、セラミドの結晶化を抑制させる点から、10〜20が好ましく、12〜20がより好ましく、14〜18がさらに好ましく、16〜18がよりさらに好ましい。
Component (B) used in the present invention is a higher alcohol having 8 to 20 carbon atoms, and examples thereof include lauryl alcohol, myristyl alcohol, cetanol, stearyl alcohol, and oleyl alcohol.
The carbon number of the higher alcohol is preferably from 10 to 20, more preferably from 12 to 20, and even more preferably from 14 to 18 from the viewpoint of suppressing crystallization of ceramide by interaction with the components (A) and (D). 16-18 are even more preferable.
成分(B)は、1種又は2種以上を組合わせて用いることができ、セラミドの結晶化を抑制し、塗布後の肌のつや感を向上させる点から、含有量は、全組成中に0.05〜6質量%であり、0.1〜5質量%が好ましく、0.5〜3.5質量%がより好ましく、0.5〜1.8質量%がさらに好ましい。 Component (B) can be used singly or in combination of two or more, and from the point of suppressing crystallization of ceramide and improving the glossiness of the skin after application, the content is in the total composition It is 0.05-6 mass%, 0.1-5 mass% is preferable, 0.5-3.5 mass% is more preferable, 0.5-1.8 mass% is further more preferable.
成分(C)のセラミド類としては、(I)天然由来のセラミド、及び/又は(II)擬
似型セラミドが好ましく、例えば、特開2013−53146号公報記載のセラミドが好ましい。
(I)天然由来のセラミド(以下、天然型セラミドという)の具体例としては、セラミドType1〜7(例えば、J. Lipid Res., 24:759(1983)の図2、及びJ. Lipid. Res.,35:2069(1994)の図4記載のブタ及びヒトのセラミド類)が挙げられる。
更に、これらのN−アルキル体(例えば、N−メチル体)も含まれる。
As the ceramides of component (C), (I) naturally-derived ceramides and / or (II) pseudo-ceramides are preferable, for example, ceramides described in JP2013-53146A are preferable.
(I) Specific examples of naturally-occurring ceramides (hereinafter referred to as natural ceramides) include ceramide types 1 to 7 (for example, FIG. 2 of J. Lipid Res., 24: 759 (1983), and J. Lipid. Res. ., 35: 2069 (1994), porcine and human ceramides described in FIG.
Furthermore, these N-alkyl bodies (for example, N-methyl body) are also included.
これらのセラミドは、天然型(D(−)体)の光学活性体を用いても、非天然型(L(+)体)の光学活性体を用いても、更に天然型と非天然型の混合物を用いてもよい。上記化合物の立体配置は、天然型の立体配置のものでも、それ以外の非天然型の立体配置のものでも良く、また、これらの混合物によるものでもよい。これらのうち、CERAMIDE1、CERAMIDE2、CERAMIDE3、CERAMIDE5、CERAMIDE6IIの化合物(以上、INCI、8th Edition)及び次式で表わされるものが好ましい。 These ceramides can be either natural or non-natural (D (-)) optically active or non-natural (L (+)) optically active. Mixtures may be used. The configuration of the compound may be a natural configuration, a non-natural configuration other than that, or a mixture thereof. Of these, compounds of CERAMIDE1, CERAMIDE2, CERAMIDE3, CERAMIDE5, CERAMIDE6II (hereinafter referred to as INCI, 8th Edition) and those represented by the following formula are preferable.
これらは天然からの抽出物及び/又は合成物のいずれでもよく、市販のものを用いることができる。
このような天然型セラミドの市販のものとしては、Ceramide I、Ceramide III、Ceramide IIIA、Ceramide IIIB、Ceramide IIIC、Ceramide VI(以上、コスモファーム社)、Ceramide TIC-001(高砂香料社)、CERAMIDE II(Quest International社)、DS-Ceramide VI、DS-CLA-Phytoceramide、Phytoceramide、DS-ceramide Y3S(DOOSAN社)、CERAMIDE2(セダーマ社)が挙げられる。
These may be natural extracts and / or synthetic products, and commercially available products may be used.
Such commercially available natural ceramides are Ceramide I, Ceramide III, Ceramide IIIA, Ceramide IIIB, Ceramide IIIC, Ceramide VI (above, Cosmo Farm), Ceramide TIC-001 (Takasago Inc.), CERAMIDE II (Quest International), DS-Ceramide VI, DS-CLA-Phytoceramide, Phytoceramide, DS-ceramide Y3S (DOOSAN), CERAMIDE2 (Cedama).
(II)擬似型セラミドとしては、次式で表されるN−(ヘキサデシロキシヒドロキシプロピル)−N−ヒドロキシエチルヘキサデカナミド、N−(ヘキサデシロキシヒドロキシプロピル)−N−ヒドロキシエチルデカナミド等が挙げられ、N−(ヘキサデシロキシヒドロキシプロピル)−N−ヒドロキシエチルヘキサデカナミド)が好ましい。 (II) As pseudo-ceramides, N- (hexadecyloxyhydroxypropyl) -N-hydroxyethylhexadecanamide, N- (hexadecyloxyhydroxypropyl) -N-hydroxyethyldecanamim represented by the following formula: N- (hexadecyloxyhydroxypropyl) -N-hydroxyethylhexadecanamide) is preferable.
成分(C)のセラミド類は、1種又は2種以上を組合わせて用いることができ、成分(C)を十分に皮膚に浸透させる点から、含有量は、全組成中に0.01〜8質量%であり、0.05〜5質量%が好ましく、0.1〜3質量%がさらに好ましい。 The ceramide of component (C) can be used alone or in combination of two or more, and from the point of sufficiently allowing component (C) to penetrate into the skin, the content is 0.01 to 8 mass%, preferably 0.05-5 mass%, more preferably 0.1-3 mass%.
本発明で用いる成分(D)のジアシルグルタミン酸リシン塩は、成分(A)及び(B)との相互作用により、セラミドの結晶化を抑制するために用いられる。
ジアシルグルタミン酸リシン塩としては、成分(A)及び(B)との相互作用により、セラミドの結晶化を抑制する点から、アシル基の炭素数が10〜18であるのが好ましく、12〜18がより好ましい。
また、これらの塩としては、ナトリウム、カリウム等のアルカリ金属塩、トリエタノールアミン塩等の有機アミン塩、アルギニン等の塩基性アミノ酸塩などが挙げられ、同様の点から、アルカリ金属塩が好ましく、ナトリウム塩がより好ましい。
成分(D)としては、成分(A)及び(B)との相互作用により、セラミドの結晶化を抑制する点から、ジラウロイルグルタミン酸リシンナトリウム、ジミリストイルグルタミン酸リシンナトリウム、ジステアロイルグルタミン酸リシンナトリウム、ジリノレオイルグルタミン酸リシンナトリウム等が好ましく、ジラウロイルグルタミン酸リシンナトリウムがより好ましい。
The diacyl glutamic acid lysine salt of component (D) used in the present invention is used to suppress crystallization of ceramide by interaction with components (A) and (B).
As the diacylglutamic acid lysine salt, the acyl group preferably has 10 to 18 carbon atoms from the viewpoint of suppressing crystallization of ceramide by interaction with the components (A) and (B). More preferred.
Examples of these salts include alkali metal salts such as sodium and potassium, organic amine salts such as triethanolamine salt, and basic amino acid salts such as arginine. From the same point, alkali metal salts are preferable, Sodium salt is more preferred.
Component (D) includes dilauroyl glutamate lysine sodium, dimyristoyl glutamate lysine sodium, distearoyl glutamate lysine sodium, dilysate from the viewpoint of suppressing crystallization of ceramide by interaction with components (A) and (B). Noreoil glutamic acid sodium lysine and the like are preferable, and dilauroyl glutamic acid sodium ricin sodium is more preferable.
ジアシルグルタミン酸リシン塩は、L−リシン塩酸塩とN−脂肪酸アシル−L−グルタミン酸無水物を反応させて合成することができる。
また、ジアシルグルタミン酸リシン塩の市販品として、例えば、旭化成ケミカルズ社製のペリセアL−30:商品名(ジラウロイルグルタミン酸リシンナトリウム、有効含有量29%、水71%)等を使用することができる。
Diacyl glutamic acid lysine salt can be synthesized by reacting L-lysine hydrochloride with N-fatty acid acyl-L-glutamic acid anhydride.
Further, as a commercially available product of diacylglutamic acid lysine salt, for example, Perisea L-30 manufactured by Asahi Kasei Chemicals Corporation: trade name (dilauroylglutamate lysine sodium, effective content 29%, water 71%) and the like can be used.
成分(D)は、1種又は2種以上を組合わせて用いることができ、成分(A)及び(B)との相互作用により、セラミドの結晶化を抑制させる点から、酸に換算した含有量(以下、酸換算量という)は、全組成中に0.01〜1.5質量%であり、0.02〜1.2質量%が好ましく、0.05〜1質量%がさらに好ましい。 Component (D) can be used singly or in combination of two or more, and contained in terms of acid in terms of inhibiting crystallization of ceramide by interaction with components (A) and (B) The amount (hereinafter referred to as acid conversion amount) is 0.01 to 1.5% by mass in the total composition, preferably 0.02 to 1.2% by mass, and more preferably 0.05 to 1% by mass.
本発明において、成分(D)の酸換算量に対する成分(A)、(B)及び(C)の合計含有量の質量割合[((A)+(B)+(C))/(D)]は、セラミドの結晶化を抑制し、塗布後の肌のなめらかさ、つや感を向上させる点から、1〜220であり、2〜150が好ましく、3〜45がより好ましい。 In the present invention, the mass ratio of the total content of components (A), (B) and (C) to the acid equivalent of component (D) [((A) + (B) + (C)) / (D) ] Is from 1 to 220, preferably from 2 to 150, and more preferably from 3 to 45, from the viewpoint of suppressing crystallization of ceramide and improving the smoothness and glossiness of the skin after application.
本発明において、成分(D)の酸換算量に対する成分(A)の質量割合[(A)/(D)]は、セラミドの結晶化を抑制し、塗布後の肌のなめらかさ、つや感を向上させる点から、0.1〜80が好ましく、0.3〜40がより好ましく、1〜12がさらに好ましい。
また、成分(D)の酸換算量に対する成分(B)の質量割合[(B)/(D)]は、セラミドの結晶化を抑制し、塗布後の肌のなめらかさ、つや感を向上させる点から、0.1〜80が好ましく、0.7〜50がより好ましく、1〜20がさらに好ましい。
さらに、成分(D)の酸換算量に対する成分(C)の質量割合[(C)/(D)]は、セラミドの結晶化を抑制し、塗布後の肌のなめらかさ、つや感を向上させる点から、0.05〜80が好ましく、0.1〜50がより好ましく、0.1〜35がさらに好ましく、1〜25がよりさらに好ましい。
また、成分(B)に対する成分(A)の質量割合[(A)/(B)]は、セラミドの結晶化を抑制し、塗布後の肌のなめらかさ、つや感を向上させる点から、0.01〜14が好ましく、0.05〜6がより好ましく、0.2〜3がさらに好ましく、0.2〜1.5がよりさらに好ましい。
In the present invention, the mass ratio [(A) / (D)] of the component (A) to the acid equivalent amount of the component (D) suppresses the crystallization of ceramide, and makes the skin smooth and glossy after application. From the point to improve, 0.1-80 are preferable, 0.3-40 are more preferable, and 1-12 are more preferable.
Moreover, the mass ratio [(B) / (D)] of the component (B) to the acid equivalent amount of the component (D) suppresses the crystallization of ceramide, and improves the smoothness and glossiness of the skin after application. From a point, 0.1-80 are preferable, 0.7-50 are more preferable, and 1-20 are more preferable.
Furthermore, the mass ratio [(C) / (D)] of the component (C) to the acid equivalent amount of the component (D) suppresses the crystallization of ceramide, and improves the smoothness and glossiness of the skin after application. From a point, 0.05-80 are preferable, 0.1-50 are more preferable, 0.1-35 are more preferable, and 1-25 are more preferable.
Further, the mass ratio [(A) / (B)] of the component (A) to the component (B) suppresses crystallization of ceramide and improves the smoothness and glossiness of the skin after application. 0.01-14 are preferable, 0.05-6 are more preferable, 0.2-3 are more preferable, and 0.2-1.5 are still more preferable.
本発明において、成分(E)の水の含有量は、全組成中に50〜95質量%が好ましく、60〜90質量%がより好ましい。 In this invention, 50-95 mass% is preferable in the whole composition, and, as for content of the water of a component (E), 60-90 mass% is more preferable.
本発明の化粧料は、さらに、(F)多価アルコールを含有することができ、成分(D)との相互作用により、つや感を向上させることができる。
多価アルコールとしては、通常の化粧料に用いられるものであれば制限されず、例えば、グリセリン、1,3−ブチレングリコール、1,3−プロパンジオール、プロピレングリコール、ジグリセリン、ジプロピレングリコール、分子量2000以下のポリエチレングリコール等が挙げられる。これらのうち、成分(D)との相互作用により、つや感を向上させる点から、グリセリン、1,3−ブチレングリコール、ジプロピレングリコールから選ばれる1種以上が好ましく、グリセリン、1,3−ブチレングリコールから選ばれる1種以上がより好ましく、グリセリンがさらに好ましい。
The cosmetic of the present invention can further contain (F) a polyhydric alcohol, and can improve glossiness by interaction with the component (D).
The polyhydric alcohol is not limited as long as it is used in ordinary cosmetics. For example, glycerin, 1,3-butylene glycol, 1,3-propanediol, propylene glycol, diglycerin, dipropylene glycol, molecular weight Examples include polyethylene glycol of 2000 or less. Among these, one or more selected from glycerin, 1,3-butylene glycol, and dipropylene glycol are preferable from the viewpoint of improving glossiness by interaction with the component (D), and glycerin, 1,3-butylene. One or more selected from glycol is more preferable, and glycerin is more preferable.
成分(F)の多価アルコールは、1種又は2種以上を組合わせて用いることができ、成分(D)と相互作用することによって、つや感をより向上させる点から、含有量は、全組成中に5〜20質量%が好ましく、7〜15質量%がより好ましい。 The polyhydric alcohol of the component (F) can be used alone or in combination of two or more, and the content is improved from the point of further improving the gloss feeling by interacting with the component (D). 5-20 mass% is preferable in a composition, and 7-15 mass% is more preferable.
本発明の化粧料は、前記以外に、通常の化粧料に用いられる成分、例えば、25℃で液状の油剤、成分(B)及び(C)以外の25℃でペースト又はワックス状の油脂、成分(A)以外の非イオン性界面活性剤、成分(D)以外のアニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、水溶性高分子、エキス類、塩基、酸、エタノール、防腐剤、香料などを含有することができる。 In addition to the above, the cosmetic of the present invention is a component used in normal cosmetics, for example, an oil that is liquid at 25 ° C., and a paste or wax-like fat or oil at 25 ° C. other than components (B) and (C) Nonionic surfactants other than (A), anionic surfactants other than component (D), cationic surfactants, amphoteric surfactants, water-soluble polymers, extracts, bases, acids, ethanol, preservatives, A fragrance | flavor etc. can be contained.
25℃で液状の油剤とは、25℃での粘度が、10,000mPa・s以下のものをいう。例えば、流動パラフィン、水添ポリイソブテン、水添ポリデセン、スクワラン等の炭化水素油;オリーブ油、ホホバオイル等の植物油;ジメチルポリシロキサン(メチルポリシロキサン)、環状ジメチルポリシロキサン、メチルフェニルポリシロキサン、アミノ変性シリコーン、カルボキシ変性シリコーン、アルコール変性シリコーン、アルキル変性シリコーン、ポリエーテル変性シリコーン、フッ素変性シリコーン等のシリコーン油;パーフルオロアルキルエチルリン酸、パーフルオロアルキルポリオキシエチレンリン酸、パーフルオロポリエーテル、ポリテトラフルオロエチレン等のフッ素系油;アルキル−1,3−ジメチルブチルエーテル、ジカプリン酸ネオペンチルグリコール等の極性油などが挙げられる。
25℃で液状の油剤は、1種又は2種以上を組合わせて用いることができ、塗布後の肌のなめらかさ、つや感を向上させる点から、含有量は、全組成中に1質量%以上が好ましく、2質量%以上がより好ましく、3質量%以上がさらに好ましく、20質量%以下が好ましく、15質量%以下がより好ましく、10質量%以下がさらに好ましく、6質量%以下がよりさらに好ましい。
The oil agent that is liquid at 25 ° C. means that the viscosity at 25 ° C. is 10,000 mPa · s or less. For example, hydrocarbon oils such as liquid paraffin, hydrogenated polyisobutene, hydrogenated polydecene, and squalane; vegetable oils such as olive oil and jojoba oil; dimethylpolysiloxane (methylpolysiloxane), cyclic dimethylpolysiloxane, methylphenylpolysiloxane, amino-modified silicone , Silicone oils such as carboxy-modified silicone, alcohol-modified silicone, alkyl-modified silicone, polyether-modified silicone, and fluorine-modified silicone; perfluoroalkylethyl phosphate, perfluoroalkylpolyoxyethylene phosphate, perfluoropolyether, polytetrafluoro Fluorine oils such as ethylene; polar oils such as alkyl-1,3-dimethylbutyl ether and neopentyl glycol dicaprate.
The liquid oil at 25 ° C. can be used alone or in combination of two or more. From the point of improving the smoothness and glossiness of the skin after coating, the content is 1% by mass in the total composition. The above is preferable, 2% by mass or more is more preferable, 3% by mass or more is more preferable, 20% by mass or less is preferable, 15% by mass or less is more preferable, 10% by mass or less is further preferable, and 6% by mass or less is still more preferable. preferable.
成分(B)及び(C)以外の25℃でペースト又はワックス状の油脂としては、例えば、ワセリン等の炭化水素油;ステアリン酸、ベヘン酸、ミリスチン酸等の直鎖の炭素数10〜22の高級脂肪酸等が挙げられる。
成分(B)及び(C)以外の25℃でペースト又はワックス状の油脂は、1種又は2種以上を組合わせて用いることができ、塗布後の肌のなめらかさ、つや感を向上させる点から、含有量は、全組成中に0.1質量%以上が好ましく、5質量%以下が好ましく、3質量%以下がより好ましく、1質量%以下がさらに好ましく、0.5質量%以下がよりさらに好ましい。
Examples of paste or waxy oils and fats other than the components (B) and (C) include hydrocarbon oils such as petrolatum; straight chain carbon number 10 to 22 such as stearic acid, behenic acid, myristic acid Higher fatty acids and the like.
A paste or wax-like oil and fat at 25 ° C. other than the components (B) and (C) can be used alone or in combination of two or more, and improves the smoothness and glossiness of the skin after application. Therefore, the content is preferably 0.1% by mass or more, preferably 5% by mass or less, more preferably 3% by mass or less, still more preferably 1% by mass or less, and more preferably 0.5% by mass or less. Further preferred.
成分(A)以外の非イオン性界面活性剤としては、、ポリオキシエチレン基を有するものが好ましく、HLBは10以上が好ましく、12.5〜15.5がより好ましい。
本発明において、HLBとは親水性−親油性のバランス(Hydrophilic-Lypophilic Balance)を示す指標であり、本発明においては、小田・寺村らによる次式を用いて算出した値を用いている。
As the nonionic surfactant other than the component (A), those having a polyoxyethylene group are preferable, the HLB is preferably 10 or more, and more preferably 12.5 to 15.5.
In the present invention, HLB is an index indicating a hydrophilic-lipophilic balance. In the present invention, a value calculated using the following equation by Oda and Teramura et al. Is used.
成分(A)以外の非イオン性界面活性剤としては、例えば、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、アルキルポリオキシエチレングリセリル、ポリオキシエチレンアルキルエーテル等が挙げられ、安定性を向上させる点から、ポリオキシエチレン硬化ヒマシ油、モノステアリン酸ポリオキシエチレンソルビタンが好ましい。
成分(A)以外の非イオン性界面活性剤は、1種又は2種以上を組合わせて用いることができ、安定性を向上させ、べたつきを低減させる点から、含有量は、全組成中に0.1質量%以上が好ましく、0.2質量%以上がより好ましく、1質量%以下が好ましく、0.5質量%以下がより好ましい。
Examples of the nonionic surfactant other than the component (A) include polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, alkyl polyoxyethylene glyceryl, polyoxyethylene alkyl ether and the like. From the viewpoint of improvement, polyoxyethylene hydrogenated castor oil and polyoxyethylene sorbitan monostearate are preferable.
Nonionic surfactants other than the component (A) can be used alone or in combination of two or more, and the content is increased in the total composition from the viewpoint of improving stability and reducing stickiness. 0.1 mass% or more is preferable, 0.2 mass% or more is more preferable, 1 mass% or less is preferable, and 0.5 mass% or less is more preferable.
成分(D)以外のアニオン界面活性剤としては、例えば、炭素数12〜24の脂肪酸を由来とする脂肪酸塩、N−ステアロイル−N−メチルタウリンナトリウム等の脂肪酸アミドスルホン酸塩、ポリオキシエチレンラウリルエーテルリン酸ナトリウム等のポリオキシエチレンアルキルエーテルリン酸エステル塩、N−ステアロイル−L−グルタミン酸アルギニン等の長鎖N−アシルグルタミン酸、アルキル硫酸エステル塩、アルキルエーテル硫酸エステル塩等が挙げられる。
成分(D)以外のアニオン性界面活性剤は、1種又は2種以上を組合わせて用いることができ、成分(D)と組合わせて塗布後の肌のつや感、安定性を向上させる点から、含有量は、酸に換算して、全組成中に0.01質量%以上が好ましく、0.05質量%以上がより好ましく、0.1質量%以上がさらに好ましく、0.2質量%以上がよりさらに好ましく、3質量%以下が好ましく、2質量%以下がより好ましく、1.5質量%以下がさらに好ましく、1質量%以下がよりさらに好ましい。
Examples of the anionic surfactant other than the component (D) include fatty acid salts derived from fatty acids having 12 to 24 carbon atoms, fatty acid amide sulfonates such as sodium N-stearoyl-N-methyltaurine, and polyoxyethylene lauryl. Examples thereof include polyoxyethylene alkyl ether phosphate salts such as sodium ether phosphate, long chain N-acyl glutamic acids such as N-stearoyl-L-glutamic acid arginine, alkyl sulfate salts, and alkyl ether sulfate salts.
Anionic surfactants other than the component (D) can be used alone or in combination of two or more, and the combination with the component (D) improves the glossiness and stability of the skin after application. Therefore, in terms of acid, the content is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, further preferably 0.1% by mass or more, and 0.2% by mass in the total composition. The above is more preferable, 3% by mass or less is preferable, 2% by mass or less is more preferable, 1.5% by mass or less is further preferable, and 1% by mass or less is more preferable.
カチオン界面活性剤、両性界面活性剤の含有量は、全組成中に1質量%以下が好ましく、0.5質量%以下がより好ましく、0.1質量%以下がさらに好ましく、実質0質量%であるのがよりさらに好ましい。 The content of the cationic surfactant and the amphoteric surfactant is preferably 1% by mass or less, more preferably 0.5% by mass or less, further preferably 0.1% by mass or less, and substantially 0% by mass in the total composition. Even more preferably.
水溶性高分子としては、例えば、カルボキシビニルポリマー、アルギン酸ナトリウム、カラギーナン、カルボキシメチルセルロース、ヒドロキシエチルセルロース、グアーガム、キサンタンガム、カルボキシメチルキトサン、ヒアルロン酸ナトリウム、オキサゾリン変性シリコーン、N,N−ジメチルアミノエチルメタクリル酸ジエチル硫酸塩・N,N−ジメチルアクリルアミド・ジメタクリル酸ポリエチレングリコール共重合体等が挙げられる。
水溶性高分子は、1種又は2種以上を組合わせて用いることができ、塗布後の肌のなめらかさ、つや感を向上させる点から、含有量は、全組成中に、0.1質量%以上が好ましく、0.15質量%以上がより好ましく、1質量%以下が好ましく、0.8質量%以下がより好ましく、0.4質量%以下がさらに好ましい。
Examples of the water-soluble polymer include carboxyvinyl polymer, sodium alginate, carrageenan, carboxymethyl cellulose, hydroxyethyl cellulose, guar gum, xanthan gum, carboxymethyl chitosan, sodium hyaluronate, oxazoline-modified silicone, diethyl N, N-dimethylaminoethyl methacrylate. Examples thereof include sulfates, N, N-dimethylacrylamide, and polyethylene glycol dimethacrylate copolymers.
The water-soluble polymer can be used alone or in combination of two or more. From the viewpoint of improving the smoothness and glossiness of the skin after application, the content is 0.1 mass in the total composition. % Or more, more preferably 0.15% by mass or more, preferably 1% by mass or less, more preferably 0.8% by mass or less, and still more preferably 0.4% by mass or less.
エキス類としては、例えば、オウバクエキス、カンゾウエキス、アロエエキス、スギナエキス、茶エキス、キューカンバーエキス、チョウジエキス、ニンジンエキス、ハマメリス抽出液、プラセンタエキス、海藻エキス、マロニエエキス、カミツレエキス、ユズエキス、チョウジエキス、アスナロエキス、アルテアエキス、ローヤルゼリーエキス、ユーカリエキス、褐藻エキス、アスナロ抽出液等の動・植物抽出液が挙げられる。
塩基としては、水酸化カリウム、水酸化ナトリウム、トリエタノールアミン、炭酸ナトリウム等が挙げられ、酸としては、クエン酸、酒石酸、乳酸、リン酸、コハク酸、アジピン酸等が挙げられる。
Extracts include, for example, buckwheat extract, licorice extract, aloe extract, horsetail extract, tea extract, cucumber extract, clove extract, carrot extract, chammel extract, placenta extract, seaweed extract, maroni extract, chamomile extract, citron extract, clove Examples include extracts of animals and plants such as extracts, asunalo extracts, altea extracts, royal jelly extracts, eucalyptus extracts, brown algae extracts, asunaro extracts.
Examples of the base include potassium hydroxide, sodium hydroxide, triethanolamine, sodium carbonate, and examples of the acid include citric acid, tartaric acid, lactic acid, phosphoric acid, succinic acid, and adipic acid.
本発明の化粧料において、塗布時の皮膚化粧料の肌への広がりを向上させる点から、エタノールの含有量は、全組成中に0.1質量%以上が好ましく、0.5質量%以上がより好ましく、6質量%以下が好ましく、5質量%以下がより好ましく、4質量%以下がさらに好ましい。 In the cosmetics of the present invention, the content of ethanol is preferably 0.1% by mass or more and 0.5% by mass or more in the total composition from the viewpoint of improving the spread of the skin cosmetics upon application to the skin. More preferably, it is preferably 6% by mass or less, more preferably 5% by mass or less, and still more preferably 4% by mass or less.
本発明の化粧料は、通常の方法により製造することができる。例えば、成分(A)、(B)、(C)を加熱混合して油相を調製し、成分(D)を(E)の一部に溶解して、界面活性剤相を調製し、油相に、界面活性剤相、その他の成分を加えて、均一に加熱混合し、その後、撹拌しながら冷却することにより、製造することができる。 The cosmetic of the present invention can be produced by a usual method. For example, components (A), (B), (C) are heated and mixed to prepare an oil phase, component (D) is dissolved in a part of (E), a surfactant phase is prepared, The surfactant phase and other components can be added to the phase, heated and mixed uniformly, and then cooled with stirring.
本発明の化粧料は、使用時の垂れにくさを向上させる点から、25℃における粘度が、1000〜50000mPa・sであるのが好ましく、2000〜40000mPa・sがより好ましく、3000〜30000mPa・sがさらに好ましい。なお、粘度は、TVB−10R形回転粘度計(東機産業社製)を用いて測定し、粘度が1000mPa・s以上20000mPa・s未満の範囲では、ローターNo.M3、20000mPa・s以上50000mPa・s以下の範囲では、ローターNo.M4を用いて、いずれも回転数6rpm、25℃で測定した値である。 The cosmetic of the present invention has a viscosity at 25 ° C. of preferably 1000 to 50000 mPa · s, more preferably 2000 to 40000 mPa · s, and more preferably 3000 to 30000 mPa · s from the viewpoint of improving the resistance to dripping during use. Is more preferable. The viscosity is measured using a TVB-10R type rotational viscometer (manufactured by Toki Sangyo Co., Ltd.). When the viscosity is in the range of 1000 mPa · s to less than 20000 mPa · s, rotor No. M3, 20000 mPa · s to 50000 mPa · s. In the range below s, all are values measured at a rotational speed of 6 rpm and 25 ° C. using rotor No. M4.
本発明の化粧料は、α−ゲル(α型結晶)であり、α−ゲルは、X線による構造解析により、確認することができる。α型構造は六方晶系のことであり、親油基が親水基層の面に対して直角に配向しており、Bragg角21〜23°付近に鋭い一本の回折ピークが現れるのが特徴である。
本発明の化粧料は、例えば、化粧水、乳液、クリーム、ジェル等として好適である。
The cosmetic of the present invention is an α-gel (α-type crystal), and the α-gel can be confirmed by structural analysis using X-rays. The α-type structure is a hexagonal system, and the lipophilic group is oriented at right angles to the surface of the hydrophilic base layer, and a sharp diffraction peak appears at a Bragg angle of 21-23 °. is there.
The cosmetic of the present invention is suitable, for example, as a lotion, milky lotion, cream, gel or the like.
実施例1〜2及び比較例1〜4
表1に示す組成の化粧料を製造し、X線による構造解析、安定性、塗布後の肌のなめらかさ及びつや感を評価した。結果を表1に併せて示す。
Examples 1-2 and Comparative Examples 1-4
Cosmetics having the compositions shown in Table 1 were produced and evaluated for structural analysis by X-ray, stability, smoothness of the skin after application, and glossiness. The results are also shown in Table 1.
(製造方法)
成分(A)、(B)及び(C)を含む油相を80〜90℃で加熱混合し、次に80〜90℃に加熱した成分(D)、(E)及び(F)を含む水相を添加し、混合した。さらに攪拌しながら25℃まで冷却して、化粧料を得た。
(Production method)
Water containing components (D), (E) and (F), wherein the oil phase containing components (A), (B) and (C) is heated and mixed at 80 to 90 ° C. and then heated to 80 to 90 ° C. The phases were added and mixed. Furthermore, it cooled to 25 degreeC, stirring, and obtained cosmetics.
(評価方法)
(1)X線による構造解折:
製造直後の化粧料について、2θ=10〜30°の広角X線回折ピークより、WilsonとOttの方法(Wilson,D.A. and Ott,E., J.Chem.Phys., 2, 231-238(1934))に従い、結晶構造を決定した。結晶構造についての評価は以下の基準で示した。
A:α型構造が確認された。
B:α型構造が確認されない。
(Evaluation method)
(1) Structural analysis by X-ray:
From the wide-angle X-ray diffraction peak of 2θ = 10-30 °, the method of Wilson and Ott (Wilson, DA and Ott, E., J. Chem. Phys., 2, 231-238 (1934) )) To determine the crystal structure. Evaluation of the crystal structure was shown by the following criteria.
A: α-type structure was confirmed.
B: α-type structure is not confirmed.
(2)安定性(室温1週間後の結晶の析出):
製造して室温保存1週間後の各化粧料について、偏光下、光学顕微鏡観察により、また、目視により、結晶の有無を確認した。結晶の有無は以下の基準で評価した。
A:光学顕微鏡観察により結晶が観察されず、目視でも観察されない。
B:光学顕微鏡観察によりわずかに結晶が観察され、目視では観察されない。
C:光学顕微鏡観察により小さな結晶が観察され、目視では観察されない。
D:光学顕微鏡観察により結晶が観察され、目視でも観察される。
(2) Stability (crystal precipitation after 1 week at room temperature):
About each cosmetic manufactured 1 week after room temperature preservation | save, the presence or absence of the crystal | crystallization was confirmed by optical microscope observation under polarization | polarized-light, and visual observation. The presence or absence of crystals was evaluated according to the following criteria.
A: Crystals are not observed by optical microscope observation, and are not observed visually.
B: Crystals are slightly observed by optical microscope observation, and are not visually observed.
C: A small crystal is observed by observation with an optical microscope and is not visually observed.
D: Crystals are observed by optical microscope observation, and are also observed visually.
(3)塗布後の肌のなめらかさ(測定値、Δμ):
人工皮革(オカモト化成品社製、セラヌバック#010)の上に、3cm×8cmの大きさに各化粧料1mLを均一に塗布した。その人工皮革をトライボギア(新東科学社製、表面性測定機、TYPE:14DR)に取り付け、化粧料を塗布してから5分後に、以下の条件で動摩擦係数の測定を行った。測定値は、測定開始から3スライド目の値(μ(化粧料塗布))をとり、化粧料を未塗布の場合の動摩擦係数(μ(未塗布))との差(Δμ)を求めることにより、肌のなめらかさを評価した。なお、Δμが小さいほど摩擦が低く、肌がなめらかであることを示す。
<条件>
・荷重 200g
・Speed 2000 mm/sec
・50mmを5スライド(2.5往復)させて測定
(Δμ)=(μ(化粧料塗布))−(μ(未塗布))
(3) Skin smoothness after application (measured value, Δμ):
On artificial leather (Okamoto Chemicals Co., Ltd., Celanu Back # 010), 1 mL of each cosmetic material was uniformly applied in a size of 3 cm × 8 cm. The artificial leather was attached to a tribogear (manufactured by Shinto Kagaku Co., Ltd., surface property measuring machine, TYPE: 14DR), and 5 minutes after applying the cosmetic, the dynamic friction coefficient was measured under the following conditions. The measured value is the value on the third slide from the start of measurement (μ (cosmetic application)), and the difference (Δμ) from the dynamic friction coefficient (μ (uncoated)) when cosmetic is not applied is obtained. , Evaluated the smoothness of the skin. In addition, it shows that friction is so low that (DELTA) micro is small and skin is smooth.
<Conditions>
・ Load 200g
・ Speed 2000 mm / sec
・ Measured with 5 slides (2.5 reciprocations) of 50 mm (Δμ) = (μ (cosmetics applied)) − (μ (not applied))
(4)塗布後の肌のなめらかさ(官能評価):
専門パネラーが、各化粧料0.2gを手の甲に指で円を描くように塗布し、塗布直後の肌を指で触ったときのなめらかさについて、以下の4段階の基準で評価した。結果は、専門パネラー3名の評価の合計値で示した。
4:非常になめらかである。
3:なめらかである。
2:わずかになめらかである。
1:なめらかでない。
(4) Skin smoothness after application (sensory evaluation):
A professional panelist applied 0.2 g of each cosmetic material on the back of the hand so as to draw a circle with a finger, and evaluated the smoothness when the skin immediately after application was touched with a finger according to the following four criteria. The results are shown as the total value of the evaluations of three professional panelists.
4: Very smooth.
3: Smooth.
2: Slightly smooth.
1: Not smooth.
(5)塗布後の肌のつや感(測定値、ΔG):
人工皮革(オカモト化成品社製、セラヌバック#010)の上に、各化粧料0.02gを3cm×3cmの大きさに均一になるように塗布し、15分後に、GlossymeterGL200(Courage+Khazaka(ドイツ)社製)を用いて、皮膚表面から直接反射した光の量=つや値 Gloss Value(G(化粧料塗布))を測定した。また、化粧料を塗布する前の未塗布のつやの値(G(未塗布))を測定し、その差(ΔG)を求め、つや感を評価した。ΔGの値が大きいほどつや感が高いことを示す。
(ΔG)=(G(化粧料塗布))−(G(未塗布))
(5) Skin gloss after application (measured value, ΔG):
On artificial leather (Okamoto Chemicals Co., Selanubak # 010), 0.02g of each cosmetic was uniformly applied to a size of 3cm x 3cm. After 15 minutes, GlossymeterGL200 (Courage + Khazaka (Germany) The amount of light directly reflected from the skin surface = gloss value (G (cosmetic application)) was measured. Moreover, the value (G (non-application)) of the uncoated gloss before apply | coating cosmetics was measured, the difference ((DELTA) G) was calculated | required, and glossiness was evaluated. It shows that glossiness is so high that the value of (DELTA) G is large.
(ΔG) = (G (cosmetics applied)) − (G (not applied))
(6)塗布後の肌のつや感(官能評価):
専門パネラーが、各化粧料0.2gを手の甲に指で円を描くように塗布し、塗布直後の肌のつや感について、以下の4段階の基準で評価した。結果は、専門パネラー3名の評価の合計値で示した。
4:つや感が非常にある。
3:つや感がある。
2:つや感がわずかにある。
1:つや感がない。
(6) Glossy feeling after application (sensory evaluation):
A specialized panelist applied 0.2 g of each cosmetic material in a circle on the back of the hand with a finger, and evaluated the glossiness of the skin immediately after application according to the following four criteria. The results are shown as the total value of the evaluations of three professional panelists.
4: Very glossy.
3: There is a feeling of gloss.
2: There is a slight glossiness.
1: There is no glossiness.
実施例3〜23
実施例1〜2と同様にして、表2、表3及び表4に示す組成の化粧料を製造し、安定性、塗布後の肌のなめらかさ及びつや感を評価した。結果を表2、表3及び表4に併せて示す。
なお、実施例3、6、7,10及び15は参考例である。
Examples 3-23
In the same manner as in Examples 1 and 2, cosmetics having the compositions shown in Tables 2, 3 and 4 were produced, and the stability, smoothness of the skin after application, and glossiness were evaluated. The results are shown in Table 2, Table 3 and Table 4.
Examples 3, 6, 7, 10 and 15 are reference examples.
Claims (5)
(A)炭素数10〜24の直鎖脂肪酸を由来とするグリセリンモノ脂肪酸エステル又はグリセリンモノアルキルエーテル 0.1〜3.5質量%、
(B)炭素数8〜20の高級アルコール 0.1〜3.5質量%、
(C)セラミド類 0.01〜8質量%、
(D)ジアシルグルタミン酸リシン塩 0.01〜1.5質量%、
(E)水
を含有し、成分(D)の酸換算量に対する成分(A)、(B)及び(C)の合計含有量の質量割合[((A)+(B)+(C))/(D)]が、2〜150である化粧料。 The following components (A), (B), (C), (D) and (E):
(A) 0.1 to 3.5 % by mass of glycerin monofatty acid ester or glycerin monoalkyl ether derived from a linear fatty acid having 10 to 24 carbon atoms,
(B) 0.1 to 3.5 % by mass of a higher alcohol having 8 to 20 carbon atoms,
(C) Ceramides 0.01-8% by mass,
(D) Diacyl glutamic acid lysine salt 0.01 to 1.5% by mass,
(E) Mass ratio of the total content of components (A), (B) and (C) with respect to the acid equivalent amount of component (D) [((A) + (B) + (C)) / (D)] is 2-150 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014246785A JP6423701B2 (en) | 2014-12-05 | 2014-12-05 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014246785A JP6423701B2 (en) | 2014-12-05 | 2014-12-05 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016108270A JP2016108270A (en) | 2016-06-20 |
JP6423701B2 true JP6423701B2 (en) | 2018-11-14 |
Family
ID=56121819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014246785A Active JP6423701B2 (en) | 2014-12-05 | 2014-12-05 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6423701B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019240119A1 (en) * | 2018-06-12 | 2019-12-19 | 花王株式会社 | W/o emulsion composition |
JP7186520B2 (en) * | 2018-06-12 | 2022-12-09 | 花王株式会社 | W/O emulsion composition |
US11896688B2 (en) * | 2018-06-12 | 2024-02-13 | Kao Corporation | W/O emulsion composition |
WO2020111067A1 (en) * | 2018-11-29 | 2020-06-04 | ロート製薬株式会社 | Composition containing ether from aliphatic alcohol and glycerin |
KR102096011B1 (en) * | 2018-12-06 | 2020-04-02 | 주식회사 코리아나화장품 | Cosmetic Composition Of α-Gel Structure Containing Ceramide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4989119B2 (en) * | 2006-06-16 | 2012-08-01 | ポーラ化成工業株式会社 | Skin external preparation suitable for vesicle system |
JP5657191B2 (en) * | 2007-06-19 | 2015-01-21 | ポーラ化成工業株式会社 | Vesicle and topical skin preparation containing the same |
JP4845071B2 (en) * | 2010-02-19 | 2011-12-28 | キユーピー株式会社 | Modified hyaluronic acid and / or salt thereof, process for producing the same and cosmetics containing the same |
WO2013022037A1 (en) * | 2011-08-09 | 2013-02-14 | 花王株式会社 | Emulsion composition |
JP2013056841A (en) * | 2011-09-08 | 2013-03-28 | Pola Chemical Industries Inc | Accelerator for forming tight junction |
KR102268945B1 (en) * | 2013-10-08 | 2021-06-23 | 큐피가부시키가이샤 | Carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof and/or production method for carboxymethyl-group-containing modified hyaluronic acid and/or salt thereof |
-
2014
- 2014-12-05 JP JP2014246785A patent/JP6423701B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016108270A (en) | 2016-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9339448B2 (en) | Emulsion composition | |
JP5961071B2 (en) | Emulsified composition | |
JP6423701B2 (en) | Cosmetics | |
JP5571258B2 (en) | Emulsified cosmetic composition | |
JP6721969B2 (en) | O/W/O type external preparation for skin | |
WO2011004589A1 (en) | Emulsified composition | |
JP5342736B2 (en) | Oil-in-water emulsion and method for producing the same | |
KR20110119774A (en) | Oily hair cosmetic | |
US10524994B2 (en) | Conditioning agent and conditioning composition | |
JP5773783B2 (en) | Moisturizing cosmetics | |
JP5690516B2 (en) | Emulsified composition | |
JP4937537B2 (en) | Hair cosmetics | |
JP6747763B2 (en) | Emulsified cosmetics | |
JP5690517B2 (en) | Emulsified composition | |
JP7324278B2 (en) | Composition containing ceramides and isobutyl oleate | |
JP6654369B2 (en) | Elastase inhibitor | |
JP2024506121A (en) | water-based emulsion | |
JP5777859B2 (en) | Emulsified composition | |
JP5973614B2 (en) | Skin cosmetics | |
JP5690980B1 (en) | Cosmetic composition | |
JP6792632B2 (en) | Emulsified cosmetics | |
JP2016222598A (en) | Skin Cosmetic | |
JP6487636B2 (en) | Skin cosmetics | |
JP2021084886A (en) | Stability composition | |
JP2018203730A (en) | Skin Cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170920 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180418 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180424 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180611 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180821 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181002 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181019 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6423701 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |